Saturday, May 25, 2024

TOPICS

Home Tags Peter Snyder

Tag: Peter Snyder

CHRISTIAN COWAN has been appointed as the University of Rhode Island Research Foundation's first executive director. / COURTESY UNIVERSITY OF RHODE ISLAND

Cowan appointed as URI Research Foundation’s new executive director

SOUTH KINGSTOWN – Christian Cowan, who has served as the University of Rhode Island Research Foundation’s chief operating officer, has been appointed as the...

URI neuroscientist gets $10.3M grant for Alzheimer’s project

SOUTH KINGSTOWN – A University of Rhode Island neuroscientist was awarded a five-year, $10.3 million grant from the National Institutes of Health to support...

RITIN forum to spotlight sustainability in textile manufacturing

SOUTH KINGSTOWN – Industry experts, elected officials and academics will come together next month to envision a greener future for the textile industry in...
Peter Snyder

Five Questions With: Peter Snyder

Peter Snyder | Deputy executive editor, Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association; University of Rhode Island vice president for research and economic development 1. You...

URI researcher named deputy executive editor of worldwide Alzheimer’s journal

SOUTH KINGSTOWN – A University of Rhode Island researcher has filled a leading role in a publication produced by the Alzheimer’s Association. Peter Snyder has...
THE UNIVERSITY OF RHODE Island, The Memory and Aging Program at Butler Hospital, and Florida-based BayCare Health System are collaborating on a retinal-screening study that could potentially help clinicians detect Alzheimer's disease earlier than is currently possible.

URI teaming up with Butler Hospital, BayCare in Florida on Alzheimer’s...

SOUTH KINGSTOWN – In a joint collaboration, the University of Rhode Island, Florida-based BayCare Health System and The Memory and Aging Program at Butler...
FURTHER STUDY: Dr. Gregory D. Jay, owner of Lubris LLC, has been investigating lubricin, a glycoprotein recently licensed to Novartis for use as a dry-eye treatment. Jay is looking into lubricin’s potential as a treatment for damaged joints and abdominal scarring prevention.  / PBN FILE PHOTO/RUPERT WHITELEY

R.I. hospitals’ dilemma: Nurture innovation or be downsized by it

Medical innovation saves and improves otherwise desperate lives and lends prestige to the hospitals nurturing it, while attracting new patients, funding, and top researchers...
MACHINE PREP: Dr. Ling Zhang, left, and Dr. Gregory D. Jay, owner of Lubris LLC, prepare the AKTA machine to purify antibodies at the Lubris lab. Lubris has licensed the glycoprotein lubricin to Novartis to use as a dry-eye treatment. / PBN PHOTO/
RUPERT WHITELEY

Lifespan researcher scores commercial hit with biolubricant Novartis deal

Dr. Gregory D. Jay, owner of Lubris LLC, is celebrating his company’s licensing of lubricin as a clinically superior dry-eye treatment to Novartis, which...
- Featured Event -

Latest News